Home » Topics » Regulatory » Health Canada

Health Canada
RSS

Graceway receives Canadian approval for topical genital warts treatment Vyloma 3.75%

March 24, 2011

Astellas' Protopic approved in Canada for prevention of eczema flares

Feb. 18, 2011

AMAG receives NON from Health Canada regarding Feraheme submission

Feb. 9, 2011

Health Canada approves Vyvanse for ADHD in adolescents and adults

Feb. 4, 2011

Prolia available in Quebec for postmenopausal osteoporosis

Feb. 3, 2011

DigiFab approved in Canada to treat digoxin toxicity/overdose

Feb. 1, 2011

Health Canada approves once-daily antidepressant Oleptro

Jan. 21, 2011

FDA and Health Canada grant telaprevir priority review for HCV infection

Jan. 21, 2011

Eli Lilly's Byetta is approved in Canada for type 2 diabetes

Jan. 19, 2011

Health Canada requests more information from Osiris regarding Prochymal approval

Jan. 18, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...